Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

2 years ago

Medical Review Committee approved initiation of recruitment of next cohort of patients, in alignment with dose optimization protocol First patient…

BrightSpring Health Services Recognizes its Valuable and Esteemed Female Leaders and Staff in Celebration of Women’s History Month

2 years ago

LOUISVILLE, Ky., March 21, 2024 (GLOBE NEWSWIRE) -- This Women’s History Month, BrightSpring Health Services, Inc. (“BrightSpring” or the “BrightSpring…

Therma Bright Announces Strategic Review & Update on Investment in Inretio

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 21, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer…

Genflow Biosciences PLC Announces Notification of Major Holdings

2 years ago

LONDON, UK / ACCESSWIRE / March 21, 2024 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW…

Genflow Biosciences PLC Announces Publication of a Key European Patent

2 years ago

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET…

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

2 years ago

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing Clinical and Regulatory Progress for…

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or…

Avinger Reports Fourth Quarter and Full Year 2023 Results

2 years ago

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in…

Music’s Healing Influence on Our Physiology

2 years ago

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20, 2024 / The relentless pace…

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

2 years ago

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…